These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15185321)

  • 21. Coexistence of HFE and rare UGT1A1 genes mutations in patients with iron overload related liver injury.
    Sikorska K; Romanowski T; Stalke P; Jaskiewicz K; Bielawski KP
    Adv Med Sci; 2010; 55(1):108-10. PubMed ID: 20371435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of iron in nonalcoholic fatty liver disease: the story continues.
    Kowdley KV
    Gastroenterology; 2010 Mar; 138(3):817-9. PubMed ID: 20116466
    [No Abstract]   [Full Text] [Related]  

  • 23. HFE mutations in nonalcoholic fatty liver disease.
    Valenti L; Dongiovanni P; Fracanzani AL; Fargion S
    Hepatology; 2008 May; 47(5):1794-5; author reply 1795-6. PubMed ID: 18438784
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
    Nash S; Marconi S; Sikorska K; Naeem R; Nash G
    Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
    Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
    Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron, the HFE gene, and hepatitis C.
    Eisenbach C; Gehrke SG; Stremmel W
    Clin Liver Dis; 2004 Nov; 8(4):775-85, vii-viii. PubMed ID: 15464655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non alcoholic steatohepatitis: a multifactorial, frequent, paucysymptomatic liver disease with a fibrotic outcome].
    Laroussi N; Mosnier JF; Morel Y; Deugnier Y; Dumas O; Audigier JC
    Gastroenterol Clin Biol; 2002 May; 26(5):475-9. PubMed ID: 12122357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease.
    Manco M; Alisi A; Real JF; Equitani F; DeVito R; Valenti L; Nobili V
    J Hepatol; 2011 Sep; 55(3):647-653. PubMed ID: 21168460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.
    Valenti L; Rametta R; Dongiovanni P; Motta BM; Canavesi E; Pelusi S; Pulixi EA; Fracanzani AL; Fargion S
    PLoS One; 2012; 7(11):e48804. PubMed ID: 23144979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathology of hepatic iron overload.
    Deugnier Y; Turlin B
    World J Gastroenterol; 2007 Sep; 13(35):4755-60. PubMed ID: 17729397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
    Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
    Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
    Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
    Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis.
    Simsek H; Balaban YH; Sümer H; Yilmaz E; Tatar G
    Dig Dis Sci; 2006 Oct; 51(10):1723-4. PubMed ID: 16964543
    [No Abstract]   [Full Text] [Related]  

  • 37. Commentary on "The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis".
    Zacharski LR; Engman CA
    Free Radic Biol Med; 2006 May; 40(10):1700-1. PubMed ID: 16678009
    [No Abstract]   [Full Text] [Related]  

  • 38. Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutations.
    Veneri D; Franchini M; Zanetti F; Krampera M; de Matteis G; Pizzolo G
    Haematologica; 2003 Sep; 88(9):1069-70. PubMed ID: 12969816
    [No Abstract]   [Full Text] [Related]  

  • 39. Iron status and HFE mutations in first-degree relatives of patients with sporadic porphyria cutanea tarda, in a Mediterranean area.
    Garcia-Morillo JS; Lorca RR; Bernabeu-Wittel M; Garcia-Junco PS; Andreu EP; de la Fuente JC
    J Intern Med; 2005 Apr; 257(4):389-90; author reply 391-3. PubMed ID: 15788010
    [No Abstract]   [Full Text] [Related]  

  • 40. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.